Company Filing History:
Years Active: 2023
Title: Jacqueline Malvin: Innovator in Coronavirus Treatment
Introduction
Jacqueline Malvin is a prominent inventor based in San Diego, CA, who has made significant contributions to the field of pharmaceutical research. She is particularly known for her work on protease inhibitors aimed at treating coronavirus infections. Her innovative approach has the potential to impact the treatment of COVID-19 significantly.
Latest Patents
Jacqueline holds one patent titled "Protease inhibitors for treatment of coronavirus infections." This patent includes compounds of Formula (I), their pharmaceutically acceptable salts, and their pharmaceutical compositions. The compounds are identified as potent inhibitors of the main protease (M) of severe acute respiratory syndrome Coronavirus-2 (SARS-CoV-2). They are designed to be useful in treating or preventing COVID-19 in a subject.
Career Highlights
Jacqueline is affiliated with The Scripps Research Institute, where she conducts her research and development. Her work is at the forefront of addressing urgent health challenges posed by viral infections, particularly in the context of the ongoing pandemic.
Collaborations
Some of her notable coworkers include Arnab Kumar Chatterjee and Jian Jeffrey Chen, who collaborate with her on various research projects. Their combined expertise enhances the potential for groundbreaking discoveries in the field of virology.
Conclusion
Jacqueline Malvin's contributions to the development of protease inhibitors represent a significant advancement in the fight against coronavirus infections. Her innovative work continues to pave the way for effective treatments that could save lives.